Skip to main content
Premium Trial:

Request an Annual Quote

Predicine, CloudHealth Ink Chinese Promotion Deal for Liquid Biopsy Cancer Tests

NEW YORK (GenomeWeb) – Predicine announced today that it has signed a deal under which it will co-promote its next-generation sequencing-based liquid biopsy cancer diagnostics in China with Shanghai-based CloudHealth Genomics.

Under the terms of the deal, CloudHealth will provide clinical genetic testing infrastructure and sequencing capacity in China for Predicine's PrediSeq cell-free DNA NGS cancer diagnostics, which are expected to launch mid-year, as well as additional tests that are slated for commercialization in "the upcoming year," the firms said.

Additional terms of the arrangement were not disclosed.

"Liquid biopsy cancer testing is being widely adopted and implemented in America, and we hope to promote it as a standard practice in hospitals thßroughout China as part of this strategic partnership with CloudHealth," Predicine President Winston Patrick Kuo said in a statement.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.